NCT04865419 2025-06-15Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesAstraZenecaPhase 1 Terminated46 enrolled 12 charts
NCT05205161 2025-01-07A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin LymphomaAstraZenecaPhase 1 Terminated7 enrolled 21 charts